A comprehensive proteomic analysis of the membrane components of HSP70+/TSG101+ EVs from HPV positive and negative cells suggested that this may be attributed to differential enrichment of biologically active membrane-associated proteins that may preferentially promote immune interactions among HPV cancers, or protect tumor cells from adverse immune or drug effects for HPV negative disease. The gene discussed is TSG101; the disease is neoplasm.